Cervical cytology classification and the Bethesda System

Area of Science:

• Gynecologic Oncology
• Cytopathology
• Public Health

Background:

• Cervical cancer screening has seen significant success in prevention.
• Early cervical cytology reporting used varied terminologies inconsistent with current understanding of cervical carcinogenesis.
• Lack of standardized terminology hindered clear clinical management guidelines.

Purpose of the Study:

• To introduce and explain the Bethesda System for reporting cervical cytology.
• To establish a uniform terminology promoting clear management guidelines for cervical cancer screening.
• To detail the evolution and updates of the Bethesda System through workshops in 1988, 1991, and 2001.

Main Methods:

• Development of the Bethesda System through consensus workshops.
• Revision and refinement of terminology based on scientific advances and clinical controversies.
• Inclusion of expert discussions and internet-based forums preceding workshops.

Main Results:

• The Bethesda System provides a standardized framework for cervical cytology reporting.
• Major revisions in the 2001 update include specimen adequacy, general categorization, and terminology for atypical epithelial cells.
• Combined "within normal limits" and "benign cellular changes" into "negative for intraepithelial lesion or malignancy."
• Removed "favor reactive" descriptors and introduced new terms aligning with management guidelines.

Conclusions:

• The Bethesda System has been widely adopted, significantly improving communication in cervical cancer screening.
• The system's standardized terminology facilitates evidence-based management and enhances patient care.
• Ongoing updates ensure the system remains current with scientific progress in cervical cancer prevention.